Clinical Trials Browser

NCT05896839 2026-03-19

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Phase 1/2 Recruiting

16 enrolled

Dermatologic

Carcinoma, Basal Cell, Melanoma, Carcinoma, Merkel Cell

NCT07482956 2026-03-19

BCC-One-Stop-Study

Phase NA Not yet recruiting

290 enrolled

Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

NCT02834013 2026-03-18

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Phase 2 Active not recruiting

818 enrolled

CNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckSarcoma

Nasopharyngeal Carcinoma, Bile Duct Neoplasms, Carcinoma, Basal Cell, Adenocarcinoma, Bronchiolo-Alveolar, Adenocarcinoma, Mucinous, Carcinoma, Transitional Cell, Carcinosarcoma, Chordoma, Carcinoma, Adenoid Cystic, Fibroma, Gallbladder Neoplasms, Hemangiosarcoma, Mouth Neoplasms, Paget Disease, Extramammary, Paraganglioma, Paranasal Sinus Neoplasms, Parathyroid Neoplasms, Pheochromocytoma, Pseudomyxoma Peritonei, Somatostatinoma, Thyroid Neoplasms, Vulvar Neoplasms, Desmoid Tumors, Seminoma, Carcinoma, Acinar Cell, Adrenocortical Carcinoma, Carcinoma, Endometrioid, Cholangiocarcinoma, Cystadenocarcinoma, Mucinous, Cystadenocarcinoma, Serous, Carcinoma, Giant Cell, Neurofibrosarcoma, Gestational Trophoblastic Disease, Rare Diseases, Gastrointestinal Stromal Tumors, Perivascular Epithelioid Cell Neoplasms

NCT02978625 2026-03-18

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Phase 2 Active not recruiting

68 enrolled

DermatologicLymphoid

Microcystic adnexal carcinoma, Adenocarcinoma, Papillary, Carcinoma, Basal Cell, Carcinoma, Basosquamous, Mycosis Fungoides, Paget Disease, Extramammary, Sezary Syndrome, Carcinoma, Merkel Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Carcinoma, Signet Ring Cell, Muir-Torre Syndrome, Eccrine Porocarcinoma

NCT07241585 2026-03-17

Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)

Phase NA Not yet recruiting

54 enrolled

Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell

NCT05814900 2026-03-13

Investigation of Mohs Surgical Margins Using Two Photon Microscopy

Phase NA Completed

135 enrolled 8 charts

Dermatologic

Carcinoma, Basal Cell

NCT06981325 2026-03-11

CEMI-first

Phase 2 Recruiting

34 enrolled

Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

NCT06919809 2026-03-09

Effectiveness and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery

Phase NA Completed

16 enrolled

Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell

NCT07227870 2026-03-09

L19IL2/TNF in Patients With Basal Cell Carcinoma

Phase 2 Not yet recruiting

92 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT07455331 2026-03-06

LANCE

Phase 2 Not yet recruiting

60 enrolled

Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

NCT04349436 2026-02-27

ARTACUS

Phase 1/2 Recruiting

90 enrolled

Dermatologic

Carcinoma, Carcinoma, Basal Cell, Neoplasms, Skin Neoplasms, Carcinoma, Merkel Cell

NCT07428941 2026-02-24

LegitHealth PH

Completed

9 enrolled

Dermatologic

Carcinoma, Basal Cell, Melanoma, Nevus, Pigmented, Skin Diseases, Urticaria, Hidradenitis Suppurativa, Keratosis, Actinic

NCT07286318 2026-02-19

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

Phase EARLY_PHASE1 Not yet recruiting

20 enrolled

Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms, Keratosis, Actinic

NCT07144384 2026-02-13

Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma

Phase EARLY_PHASE1 Recruiting

40 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT06624475 2026-02-05

NEON

Phase 2 Recruiting

30 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT07182240 2026-02-04

Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas

Phase NA Recruiting

60 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT07384078 2026-02-03

HIFUvsCRYO

Phase NA Not yet recruiting

294 enrolled

Dermatologic

Bowen's Disease, Carcinoma, Basal Cell

NCT06623201 2026-01-29

Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas

Phase 1 Recruiting

20 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT06422936 2026-01-26

SPOTLIGHT204

Phase 2 Active not recruiting

60 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT07257094 2026-01-26

Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Rehabilitation Following Nasal Skin Cancer

Recruiting

346 enrolled

Dermatologic

Carcinoma, Carcinoma, Basal Cell, Carcinoma, Squamous Cell

NCT07361666 2026-01-23

HFUS-CLEAR

Not yet recruiting

400 enrolled

Dermatologic

Margins of Excision, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Recurrence, Skin Neoplasms

NCT05212246 2026-01-22

B3C

Phase 3 Not yet recruiting

1,630 enrolled

Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Patient Compliance, Keratosis, Actinic

NCT07358637 2026-01-22

Artificial Intelligence Enhanced Optical Coherence Tomography (AI-OCT) Imaging for Pre-surgical Margin Detection of Basal Cell Carcinoma

Not yet recruiting

30 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT03889912 2026-01-21

Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma

Phase 1 Completed

97 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT07347392 2026-01-16

DOSCA-2

Enrolling by invitation

2,900 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT04616248 2026-01-07

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

Phase 1 Active not recruiting

14 enrolled

BreastDermatologicSarcoma

Bone Neoplasms, Breast Neoplasms, Carcinoma, Basal Cell, Melanoma, Sarcoma, Osteosarcoma, Carcinoma, Merkel Cell

NCT07311070 2026-01-06

Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue

Phase 3 Enrolling by invitation

20 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT07285044 2025-12-22

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Phase 2 Recruiting

27 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidMyeloidPlasma cellThoracic

Amyloidosis, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Basal Cell, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Glioblastoma, Carcinoma, Hepatocellular, Hodgkin Disease, Lung Neoplasms, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Lymphoma, Mantle-Cell